Press release
Fetal Bovine Serum Market Thrives with Trends, Growth, and Key Market Insights
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033
The Business Research Company offers in-depth market insights through Fetal Bovine Serum Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The fetal bovine serum market size has grown strongly in recent years. It will grow from $1095.25 billion in 2023 to $1176.47 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to expansion of biopharmaceutical industry, rise in cell-based therapies, quality and consistency requirements.
The fetal bovine serum market size is expected to see strong growth in the next few years. It will grow to $1644.06 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing adoption of cell therapies, emergence of advanced therapeutics, focus on animal-free alternatives, strategic supplier-customer relationships. Major trends in the forecast period include focus on quality and traceability, global collaboration and partnerships, strategic mergers and acquisitions, customized fetal bovine serum products, regulatory compliance and ethical sourcing.
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=4109&type=smp
Market Segmentation:
The fetal bovine serum market covered in this report is segmented -
1) By Product: Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum, Exosome Depleted, Stem Cell, Other Products
2) By Application: Drug Discovery, Cell Culture Media, In Vitro Fertilization, Human and Animal Vaccine Production, Diagnostics, Other Applications
3) By End-User: Research and Academic Institutes, Biotechnology and Pharmaceutical Industry, Other End-Users
Major Driver - Surging Demand Drives Growth In The Fetal Bovine Serum Market
The increase in demand for biopharmaceuticals is expected to drive the growth of the fetal bovine serum market in the forecast period. A biopharmaceutical is a medicinal product that is derived from biological sources such as animals, humans, and microorganisms using biotechnology. Fetal bovine serum (FBS) is the most widely used substitute for animal cell culture media. Pharmaceutical firms, diagnostic laboratories, and researchers rely heavily on FBS for much of their cell culture requirements in biologics research. In 2022, ProClinical Limited, a UK-based lifesciences service and consulting company, sales for the company's pharmaceuticals and vaccines segments added up to US$36.15mn, an increase of 11% YOY. Therefore, the rising demand for biopharmaceuticals propels the growth of the fetal bovine serum market.
Competitive Landscape:
Major companies operating in the fetal bovine serum market report are Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare, Corning Incorporated, Cytiva, VWR International, Sartorius AG, Bio-Techne Corporation, Atlas Biologicals Inc., R&D Systems Inc., Atlanta Biologicals Inc., Cyagen Biosciences, GenClone Inc., Gemini Bio-Products, Access Biologicals LLC, Nucleus Biologics, ZenBio Inc., Biowest, Wellington Laboratories Inc., Bovogen Biologicals Pty Ltd., TCS Biosciences Ltd., J R Scientific Inc., Rocky Mountain Biologicals Inc., Tissue Culture Biologicals, Moregate Biotech, Cell Applications Inc., Altogen Biosystems, Axil Scientific Pte Ltd., Animal Technologies Inc., PAN- Biotech, PAA Laboratories GmbH, Peak Serum Inc., Biochrom GmbH
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/fetal-bovine-serum-global-market-report
Top Trend - Leading Companies Prioritize USDA-Approved Products For Reliable And Safe Research Applications
Major companies operating in the fetal bovine serum industry are developing and focusing on innovative products such as USDA-approved fetal bovine serum to meet the needs of researchers and their budgets, offering consistent quality and value for basic research. USDA-approved fetal bovine serum is used to provide a high-quality serum that meets the rigorous safety standards set by the United States Department of Agriculture (USDA), and it is tested for the absence of specific diseases, making it a reliable option for various research and production applications. For instance, in August 2021, Thermo Fisher Scientific Inc., a US-based biotechnology company, introduced Gibco Fetal Bovine Serum. Thermo Fisher Scientific's GibcoTM Fetal Bovine Serum is a qualified, heat-inactivated, USDA-approved product suitable for basic cell culture, specialty research, and specific assays. It is USDA-approved in North America and qualified in other regions, like Brazil. The product offers excellent value for research needs and budgets, with consistent quality and award-winning support from Gibco. It is ISO 13485-certified and processed in FDA-registered facilities. The product is suitable for cell culture with robust cell lines and has an endotoxin level of ≤ 20 EU/mL.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Fetal Bovine Serum Market Characteristics
3. Fetal Bovine Serum Market Trends And Strategies
4. Fetal Bovine Serum Market - Macro Economic Scenario
5. Fetal Bovine Serum Market Size And Growth
…..
27. Fetal Bovine Serum Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
The Business Research Company offers in-depth market insights through Fetal Bovine Serum Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The fetal bovine serum market size has grown strongly in recent years. It will grow from $1095.25 billion in 2023 to $1176.47 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to expansion of biopharmaceutical industry, rise in cell-based therapies, quality and consistency requirements.
The fetal bovine serum market size is expected to see strong growth in the next few years. It will grow to $1644.06 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing adoption of cell therapies, emergence of advanced therapeutics, focus on animal-free alternatives, strategic supplier-customer relationships. Major trends in the forecast period include focus on quality and traceability, global collaboration and partnerships, strategic mergers and acquisitions, customized fetal bovine serum products, regulatory compliance and ethical sourcing.
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=4109&type=smp
Market Segmentation:
The fetal bovine serum market covered in this report is segmented -
1) By Product: Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum, Exosome Depleted, Stem Cell, Other Products
2) By Application: Drug Discovery, Cell Culture Media, In Vitro Fertilization, Human and Animal Vaccine Production, Diagnostics, Other Applications
3) By End-User: Research and Academic Institutes, Biotechnology and Pharmaceutical Industry, Other End-Users
Major Driver - Surging Demand Drives Growth In The Fetal Bovine Serum Market
The increase in demand for biopharmaceuticals is expected to drive the growth of the fetal bovine serum market in the forecast period. A biopharmaceutical is a medicinal product that is derived from biological sources such as animals, humans, and microorganisms using biotechnology. Fetal bovine serum (FBS) is the most widely used substitute for animal cell culture media. Pharmaceutical firms, diagnostic laboratories, and researchers rely heavily on FBS for much of their cell culture requirements in biologics research. In 2022, ProClinical Limited, a UK-based lifesciences service and consulting company, sales for the company's pharmaceuticals and vaccines segments added up to US$36.15mn, an increase of 11% YOY. Therefore, the rising demand for biopharmaceuticals propels the growth of the fetal bovine serum market.
Competitive Landscape:
Major companies operating in the fetal bovine serum market report are Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare, Corning Incorporated, Cytiva, VWR International, Sartorius AG, Bio-Techne Corporation, Atlas Biologicals Inc., R&D Systems Inc., Atlanta Biologicals Inc., Cyagen Biosciences, GenClone Inc., Gemini Bio-Products, Access Biologicals LLC, Nucleus Biologics, ZenBio Inc., Biowest, Wellington Laboratories Inc., Bovogen Biologicals Pty Ltd., TCS Biosciences Ltd., J R Scientific Inc., Rocky Mountain Biologicals Inc., Tissue Culture Biologicals, Moregate Biotech, Cell Applications Inc., Altogen Biosystems, Axil Scientific Pte Ltd., Animal Technologies Inc., PAN- Biotech, PAA Laboratories GmbH, Peak Serum Inc., Biochrom GmbH
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/fetal-bovine-serum-global-market-report
Top Trend - Leading Companies Prioritize USDA-Approved Products For Reliable And Safe Research Applications
Major companies operating in the fetal bovine serum industry are developing and focusing on innovative products such as USDA-approved fetal bovine serum to meet the needs of researchers and their budgets, offering consistent quality and value for basic research. USDA-approved fetal bovine serum is used to provide a high-quality serum that meets the rigorous safety standards set by the United States Department of Agriculture (USDA), and it is tested for the absence of specific diseases, making it a reliable option for various research and production applications. For instance, in August 2021, Thermo Fisher Scientific Inc., a US-based biotechnology company, introduced Gibco Fetal Bovine Serum. Thermo Fisher Scientific's GibcoTM Fetal Bovine Serum is a qualified, heat-inactivated, USDA-approved product suitable for basic cell culture, specialty research, and specific assays. It is USDA-approved in North America and qualified in other regions, like Brazil. The product offers excellent value for research needs and budgets, with consistent quality and award-winning support from Gibco. It is ISO 13485-certified and processed in FDA-registered facilities. The product is suitable for cell culture with robust cell lines and has an endotoxin level of ≤ 20 EU/mL.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Fetal Bovine Serum Market Characteristics
3. Fetal Bovine Serum Market Trends And Strategies
4. Fetal Bovine Serum Market - Macro Economic Scenario
5. Fetal Bovine Serum Market Size And Growth
…..
27. Fetal Bovine Serum Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
